Workshop 4
Vaccines 1

Programme

• 17:45 – 18:00 12 Min. 3 Min.

  • Abstract talk
  • O 019

  Mucosal vaccination with a viral vector vaccine protects against pulmonary 4T1 metastasis and synergizes with radiotherapy

  • Friederike Oltmanns (Erlangen / DE)

   Vaccines
• 18:00 – 18:15 12 Min. 3 Min.

  • Abstract talk
  • O 020

  Protective MVA-ST vaccination robustly activates T Cells and antibodies in an Aged-Hamster model for COVID-19

  • Sabrina Clever (Hannover / DE)

   Vaccines
• 18:15 – 18:30 12 Min. 3 Min.

  • Abstract talk
  • O 021

  Correlates of protection against MERS-CoV in mice immunized with a S protein-encoding measles-derived vaccine candidate

  • Dr. Aileen Ebenig (Langen / DE)

   Vaccines
• 18:30 – 18:45 12 Min. 3 Min.

  • Abstract talk
  • O 022

  Subunit vaccines based on fowl adenovirus (FAdV) recombinant fiber proteins stimulate protective humoral and cellular immune pathways in chickens

  • Dr. Carlotta De Luca (Vienna / AT)

   Vaccines
• 18:45 – 19:00 12 Min. 3 Min.

  • Abstract talk
  • O 023

  An Arenavirus-Based SIV vaccine is immunogenic and efficacious in non-human primates

  • Dr. Sarah Schmidt (Vienna / AT)

   Vaccines
• 19:00 – 19:15 12 Min. 3 Min.

  • Abstract talk
  • O 024

  Monoclonal antibodies (mAbs) against L2 and chimeric virus-like particles (VLP) cross-protect against beta human papillomaviruses (HPV) implicated in skin cancer development

  • Dr. Bettina Huber (Vienna / AT)

   Vaccines